As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access.
Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies.
To explore this issue further, let’s look at the key findings of this groundbreaking new research.
Similar to Veriheal, Nugg MD connects MMJ patients to physicians via telemedicine.
Their newly unleashed powerful study suggests the need for greater access to cannabis-based medical treatments and more robust protection of healthcare professionals exploring these options with their patients. Here’s what the study found:
Nugg MD’s research explored the motivations behind people’s use of medical cannabis, uncovering fascinating insights about why this treatment is increasingly sought-after.
They found that most patients apply for an MMJ card to alleviate the following:
While most medical marijuana patients utilize it to treat one of their state’s listed conditions, a select few are tapping into its potential for treating unlisted ailments.
Perhaps there’s more complexity behind their decision-making process than meets the eye—especially since they likely have to select different conditions depending on what is legally available in their state.
To understand this concept, imagine a cannabis-friendly state makes provisions for eight qualifying conditions:
While a more restrictive state only makes provisions for five:
The problem is, in the more restrictive states, if patients require medical marijuana for autoimmune disorders or PTSD, they have no choice but to present it as “other conditions”—like anxiety, which anyone can experience at any time.
Nugg MD’s report suggests there is more to unpack when analyzing healthcare disparities related to MMJ access. Although respondents frequently have to choose “other conditions” to meet MMJ requirements, it’s an unfortunate reality for millions due to restrictive laws and policies, further skewing data towards more universally accepted health issues.
Despite ongoing political debates about the limitations of medical marijuana programs, a 2019 study published in the Journal of Patient-Centered Research and Reviews provided further evidence of how MMJ-restrictive states inadvertently impact their patients.
According to the study, individuals living in states where medical cannabis is difficult to access are more likely to resort to prescription drugs to treat chronic pain or other debilitating conditions.
This suggests that not only may MMJ-restrictive states be failing their citizens by denying access to a proven therapy option, but they may also be unknowingly fostering habits that could increase the risks associated with the long-term use of potentially deadly pharmaceutical medications.
Despite the immense potential of cannabis, its status as a Schedule I drug has been an obstacle in furthering research on the plant. In addition to decades-old stigmas attached to it and its users, progress has been stifled by legal factors that are gradually changing through advocacy and patient support.
Furthermore, Nugg MD’s data shows just how vital MMJ access has become in modern society’s health landscape. However, this study speaks to another dire need for the future: better data collection.
Accurate cannabis data has a unique significance, specifically, when it comes to increasing the number of qualifying conditions nationwide and expanding access–something that can benefit everyone, from patients, practitioners, and policymakers alike.
In states that restrict medical cannabis access, patients and doctors are both negatively affected in a number of ways. The study mentioned above makes it clear that restrictive MMJ policies may be exacerbating the problems of opioid abuse and drug overdose deaths in the United States.
As the world moves towards a more accepting view of plant-based medicine, it’s becoming increasingly difficult for lawmakers to justify keeping restrictions in place. Lawmakers should seize this opportunity to make access to MMJ easier and remove the stigma unfairly cast on those seeking relief from their ailments.
Note: The content on this page is for informational purposes only and is not intended to be professional medical advice. Do not attempt to self-diagnose or prescribe treatment based on the information provided. Always consult a physician before making any decision on the treatment of a medical condition.
Blunts: What are they exactly, and how do they affect your body? If you’re interested in smoking blunts—or already smoke them—this guide is for you. We’ll cover everything you need to know about this popular cannabis intake method, including how they’re made, how they differ from spliffs and joints, risks of use, and alternative intake…
“Stoned,” “high,” “tripping,” and “baked,” are all terms engrained in the cannabis community. These metaphorical descriptions contribute to how we perceive, interpret, and learn from the experiences produced by cannabis consumption. Cannabis experiences, of course, are unique and highly variable. Specific plant strains, the presence of other cannabinoids, different delivery methods, and a user’s individual…
Thanks to the growing wave of legalization, more consumers than ever can grow their own cannabis right at home. Growing essentials that used to be secretive are now bought and sold freely. This includes items, like grow tents, nutrients, LED lighting, HPS lighting, ventilation, and more. Keeping all these items straight is hard enough, but…
Skin diseases plague millions of individuals, inflicting both physical discomforts in addition to mental and social stress. Thankfully, there is no shortage of skin treatment options available on the market. That said, this established market may soon be in for a major shake-up if recent cannabis research is any indication. Traditionally, cannabis research focused on studying…
As more states move toward legalization, accurately detecting impaired driving is of the utmost importance. Field Sobriety Tests (FSTs) have long been the go-to method for law enforcement to assess driver impairment caused by substances like alcohol. However, a recent 2023 study published in JAMA Psychiatry raises serious questions about the accuracy of these tests…
